ROYAL BANK OF CANADA - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 120 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$877,000
-59.8%
707,848
-0.1%
0.00%
-100.0%
Q1 2017$2,181,000
-25.5%
708,334
-1.3%
0.00%
-50.0%
Q4 2016$2,928,000
-35.5%
717,754
+0.4%
0.00%
-33.3%
Q3 2016$4,540,000
+15.7%
715,064
-1.8%
0.00%
+50.0%
Q2 2016$3,925,000
-35.7%
728,334
-0.2%
0.00%
-50.0%
Q1 2016$6,105,000
+18.1%
729,484
+11.5%
0.00%
+33.3%
Q4 2015$5,170,000
+1026.4%
654,297
+1114.8%
0.00%
Q3 2015$459,000
-40.2%
53,862
-13.3%
0.00%
-100.0%
Q2 2015$767,000
+9.3%
62,103
+5.1%
0.00%
Q1 2015$702,000
-59.1%
59,103
-61.1%
0.00%
-100.0%
Q4 2014$1,715,000
+74.5%
151,803
+35.5%
0.00%0.0%
Q3 2014$983,000
+32.8%
112,003
+10.3%
0.00%0.0%
Q2 2014$740,000
+42.3%
101,503
-1.5%
0.00%
Q1 2014$520,000
+4627.3%
103,003
+4804.9%
0.00%
Q4 2013$11,000
-35.3%
2,100
-51.8%
0.00%
Q3 2013$17,000
+30.8%
4,353
+112.3%
0.00%
Q2 2013$13,0002,0500.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2017
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 514,853$2,595,0002.23%
GARRISON BRADFORD & ASSOCIATES INC 98,001$494,0000.48%
Catalyst Capital Advisors LLC 380,896$1,920,0000.44%
Knoll Capital Management, LLC 160,585$809,0000.42%
Tekla Capital Management LLC 757,050$3,816,0000.38%
FULLER & THALER ASSET MANAGEMENT, INC. 524,800$2,645,0000.13%
Integre Asset Management, LLC 103,493$522,0000.12%
CAMBRIDGE TRUST CO 220,003$1,109,0000.10%
JAMISON EATON & WOOD INC /NJ 62,782$316,0000.09%
STONERIDGE INVESTMENT PARTNERS LLC 88,304$445,0000.09%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders